| Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The Lancet 390 (10113), 2627-2642, 2017 | 3248 | 2017 |
| Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants NCD Risk Factor Collaboration The Lancet 387 (10026), 1377-1396, 2016 | 3225 | 2016 |
| Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ... The Lancet 389 (10064), 37-55, 2017 | 1342 | 2017 |
| Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1· 8 … Y Lu, K Hajifathalian, M Ezzati, M Woodward, EB Rimm, G Danaei Lancet (London, England) 383 (9921), 970-983, 2013 | 621 | 2013 |
| Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo … S Malhotra-Kumar, C Lammens, S Coenen, K Van Herck, H Goossens The Lancet 369 (9560), 482-490, 2007 | 557 | 2007 |
| Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey K Van Herck, F Castelli, J Zuckerman, H Nothdurft, P Van Damme, ... Journal of travel medicine 11 (1), 3-8, 2004 | 432 | 2004 |
| A century of trends in adult human height NCD Risk Factor Collaboration Elife 5, e13410, 2016 | 357* | 2016 |
| Hepatitis A booster vaccination: is there a need? P Van Damme, J Banatvala, O Fay, S Iwarson, B McMahon, K Van Herck, ... The lancet 362 (9389), 1065-1071, 2003 | 279 | 2003 |
| Rising rural body-mass index is the main driver of the global obesity epidemic in adults NCD Risk Factor Collaboration Nature 569 (7755), 260, 2019 | 254 | 2019 |
| A review of the long-term protection after hepatitis A and B vaccination P Van Damme, K Van Herck Travel medicine and infectious disease 5 (2), 79-84, 2007 | 175 | 2007 |
| Long-term persistence of anti-HPV-16 and-18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses MP David, K Van Herck, K Hardt, F Tibaldi, G Dubin, D Descamps, ... Gynecologic oncology 115 (3), S1-S6, 2009 | 174 | 2009 |
| Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study T Braeckman, K Van Herck, N Meyer, JY Pirçon, M Soriano-Gabarró, ... Bmj 345, 2012 | 150 | 2012 |
| Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study K Van Herck, J Zuckerman, F Castelli, P Van Damme, E Walker, R Steffen, ... Journal of travel medicine 10 (2), 75-78, 2003 | 146* | 2003 |
| Malnutrition and associated factors in nursing home residents: A cross-sectional, multi-centre study M Verbrugghe, D Beeckman, A Van Hecke, K Vanderwee, K Van Herck, ... Clinical nutrition 32 (3), 438-443, 2013 | 145 | 2013 |
| Inactivated hepatitis A vaccine‐induced antibodies: follow‐up and estimates of long‐term persistence K Van Herck, P Van Damme Journal of medical virology 63 (1), 1-7, 2001 | 119 | 2001 |
| Rotavirus vaccines in Belgium: policy and impact T Braeckman, K Van Herck, M Raes, A Vergison, M Sabbe, P Van Damme The Pediatric infectious disease journal 30 (1), S21-S24, 2011 | 95 | 2011 |
| Safety and immunogenicity of glycoprotein D—adjuvant genital herpes vaccine DI Bernstein, FY Aoki, SK Tyring, LR Stanberry, CS Pierre, SD Shafran, ... Clinical infectious diseases 40 (9), 1271-1281, 2005 | 95 | 2005 |
| Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology G Hendrickx, K Van Herck, A Vorsters, S Wiersma, C Shapiro, JK Andrus, ... Journal of viral hepatitis 15, 1-15, 2008 | 94 | 2008 |
| Mathematical models for assessment of long‐term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines K Van Herck, P Beutels, P Van Damme, M Beutels, J Van den Dries, ... Journal of medical virology 60 (1), 1-7, 2000 | 85 | 2000 |
| A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine P Van Damme, K Van Herck Expert review of vaccines 3 (3), 249-267, 2004 | 83 | 2004 |
Andreas HoltermannProfessor, National Research Centre for the Working EnvironmentVerified email at nrcwe.dk
